PARIS (Reuters) - French drugmaker Sanofi-Aventis said on Wednesday that its troubled obesity-fighting product Acomplia had won approval from the National Institute for Health and Clinical Excellence (NICE).
PARIS (Reuters) - French drugmaker Sanofi-Aventis said on Wednesday that its troubled obesity-fighting product Acomplia had won approval from the National Institute for Health and Clinical Excellence (NICE).